Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
11.30
-0.11 (-0.92%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Neogen Revenue
In the fiscal year ending May 31, 2026, Neogen had annual revenue of $870.40M, down -2.72%. Neogen had revenue of $225.30M in the quarter ending May 31, 2026, a decrease of -0.09%.
Revenue (ttm)
$870.40M
Revenue Growth
-2.72%
P/S Ratio
2.80
Revenue / Employee
$330,197
Employees
2,636
Market Cap
2.46B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2026 | 870.40M | -24.30M | -2.72% |
| May 31, 2025 | 894.70M | -29.50M | -3.19% |
| May 31, 2024 | 924.20M | 101.75M | 12.37% |
| May 31, 2023 | 822.45M | 295.29M | 56.01% |
| May 31, 2022 | 527.16M | 58.70M | 12.53% |
| May 31, 2021 | 468.46M | 50.29M | 12.03% |
| May 31, 2020 | 418.17M | 3.98M | 0.96% |
| May 31, 2019 | 414.19M | 16.26M | 4.09% |
| May 31, 2018 | 397.93M | 39.65M | 11.07% |
| May 31, 2017 | 358.28M | 37.00M | 11.52% |
| May 31, 2016 | 321.28M | 38.20M | 13.50% |
| May 31, 2015 | 283.07M | 35.67M | 14.42% |
| May 31, 2014 | 247.41M | 39.88M | 19.22% |
| May 31, 2013 | 207.53M | 23.48M | 12.76% |
| May 31, 2012 | 184.05M | 11.36M | 6.58% |
| May 31, 2011 | 172.68M | 32.17M | 22.90% |
| May 31, 2010 | 140.51M | 21.79M | 18.35% |
| May 31, 2009 | 118.72M | 16.30M | 15.92% |
| May 31, 2008 | 102.42M | 16.28M | 18.90% |
| May 31, 2007 | 86.14M | 13.71M | 18.92% |
| May 31, 2006 | 72.43M | 9.68M | 15.42% |
| May 31, 2005 | 62.76M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enovis | 2.30B |
| Haemonetics | 1.35B |
| Inspire Medical Systems | 898.74M |
| iRhythm Holdings | 787.85M |
| NovoCure | 699.19M |
| TransMedics Group | 668.47M |
| UFP Technologies | 631.64M |
| Axogen | 251.17M |
NEOG News
- 3 days ago - Neogen price target raised to $13 from $11 at Piper Sandler - TheFly
- 7 days ago - Neogen Earnings Call Transcript: Q4 2026 - Transcripts
- 7 days ago - Neogen Earnings release: Q4 2026 - Filings
- 7 days ago - Neogen Slides: Q4 2026 - Filings
- 7 days ago - Neogen Annual report: Q4 2026 - Filings
- 7 days ago - Neogen reports Q4 adjusted EPS 9c, consensus 6c - TheFly
- 7 days ago - Neogen sees FY27 revenue $880M-$885M, consensus $849.08M - TheFly
- 7 days ago - Neogen sees Q1 revenue $207M-$209M, consensus $204.7M - TheFly